{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:44:43Z","timestamp":1792601083979,"version":"4.5.0"},"reference-count":53,"publisher":"MyJove Corporation","issue":"207","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/66740","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T20:04:15Z","timestamp":1717185855000},"source":"Crossref","is-referenced-by-count":0,"title":["Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies"],"prefix":"10.3791","author":[{"given":"Adriana C.","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadel M.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscylla G. M.","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio H.","family":"Freitas-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina B.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"ref1","article-title":"WHO fact sheet. Chagas disease (also known as American trypanosomiasis)","volume-title":"WHO, World Health Organization","year":"2023","unstructured":"WHO, World Health Organization. WHO fact sheet. Chagas disease (also known as American trypanosomiasis). At https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis) (2023)."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","type":"journal-article","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","unstructured":"Lee, B. Y., Bacon, K. M., Bottazzi, M. E., Hotez, P. J. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 13 (4), 342-348 (2013).","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMra1410150","type":"journal-article","article-title":"Chagas' disease","volume":"373","author":"Bern","year":"2015","unstructured":"Bern, C. Chagas' disease. N Engl J Med. 373 (5), 456-466 (2015).","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/cir956","type":"journal-article","article-title":"Oral transmission of Chagas disease","volume":"54","author":"Shikanai-Yasuda","year":"2012","unstructured":"Shikanai-Yasuda, M. A., Carvalho, N. B. Oral transmission of Chagas disease. Clin Infect Dis. 54 (6), 845-852 (2012).","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","type":"journal-article","article-title":"Chagas disease: From discovery to a worldwide health problem","volume":"7","author":"Lidani","year":"2019","unstructured":"Lidani, K. C. F. et al. Chagas disease: From discovery to a worldwide health problem. Front Public Health. 7, 166 (2019).","journal-title":"Front Public Health"},{"issue":"10115","key":"ref6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","type":"journal-article","article-title":"Chagas disease","volume":"391","author":"Perez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina, J. A., Molina, I. Chagas disease. Lancet. 391 (10115), 82-94 (2018).","journal-title":"Lancet"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrmicro.2017.69","type":"journal-article","article-title":"Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","unstructured":"Field, M. C. et al. Anti-trypanosomatid drug discovery: An ongoing challenge and a continuing need. Nat Rev Microbiol. 15 (7), 447 (2017).","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"105107","DOI":"10.1016\/j.actatropica.2019.105107","type":"journal-article","article-title":"Drug discovery for chagas disease: A viewpoint","volume":"198","author":"Kratz","year":"2019","unstructured":"Kratz, J. M. Drug discovery for chagas disease: A viewpoint. Acta Trop. 198, 105107 (2019).","journal-title":"Acta Trop"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"e2571","DOI":"10.1371\/journal.pntd.0002571","type":"journal-article","article-title":"Highly sensitive in vivo imaging of Trypanosoma brucei expressing 'red-shifted' luciferase","volume":"7","author":"McLatchie","year":"2013","unstructured":"McLatchie, A. P. et al. Highly sensitive in vivo imaging of Trypanosoma brucei expressing 'red-shifted' luciferase. PLoS Negl Trop Dis. 7 (11), e2571 (2013).","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1087057114552623","type":"journal-article","article-title":"A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging","volume":"20","author":"Lewis","year":"2015","unstructured":"Lewis, M. D., Francisco, A. F., Taylor, M. C., Kelly, J. M. A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imaging. J Biomol Screen. 20 (1), 36-43 (2015).","journal-title":"J Biomol Screen"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"e0006388","DOI":"10.1371\/journal.pntd.0006388","type":"journal-article","article-title":"Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR\/Cas9 functionality for rapid in vivo localisation and phenotyping","volume":"12","author":"Costa","year":"2018","unstructured":"Costa, F. C. et al. Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR\/Cas9 functionality for rapid in vivo localisation and phenotyping. PLoS Negl Trop Dis. 12 (4), e0006388 (2018).","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/cmi.12297","type":"journal-article","article-title":"Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection","volume":"16","author":"Lewis","year":"2014","unstructured":"Lewis, M. D. et al. Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Cell Microbiol. 16 (9), 1285-1300 (2014).","journal-title":"Cell Microbiol"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1128\/AAC.00520-15","type":"journal-article","article-title":"Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging","volume":"59","author":"Francisco","year":"2015","unstructured":"Francisco, A. F. et al. Limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging. Antimicrob Agents Chemother. 59 (8), 4653-4661 (2015).","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","type":"journal-article","article-title":"The arrive guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"du Sert","year":"2020","unstructured":"du Sert, N. P. et al. The arrive guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18 (7), e3000410 (2020).","journal-title":"PLoS Biol"},{"issue":"5","key":"ref15","first-page":"600","type":"journal-article","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","unstructured":"Turner, P. V, Brabb, T., Pekow, C., Vasbinder, M. A. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 50 (5), 600-613 (2011).","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"5","key":"ref16","first-page":"614","type":"journal-article","article-title":"Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation","volume":"50","author":"Turner","year":"2011","unstructured":"Turner, P. V, Pekow, C., Vasbinder, M. A., Brabb, T. Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute preparation. J Am Assoc Lab Anim Sci. 50 (5), 614-627 (2011).","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"35351","DOI":"10.1038\/srep35351","type":"journal-article","article-title":"Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage","volume":"6","author":"Francisco","year":"2016","unstructured":"Francisco, A. F. et al. Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage. Sci Rep. 6, 35351 (2016).","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","type":"journal-article","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"4","author":"Moraes","year":"2014","unstructured":"Moraes, C. B. et al. Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development. Sci Rep. 4, 4703 (2014).","journal-title":"Sci Rep"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nmeth.2413","type":"journal-article","article-title":"A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum","volume":"10","author":"Shaner","year":"2013","unstructured":"Shaner, N. C. et al. A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. Nat Methods. 10 (5), 407-409 (2013).","journal-title":"Nat Methods"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.7476\/9788575413937","type":"book","volume-title":"Chagas Disease: Manual for Animal Experimentation","author":"de Ara\u00fajo-Jorge","year":"2000","unstructured":"de Ara\u00fajo-Jorge, T. C., de Castro, S. L. Chagas Disease: Manual for Animal Experimentation. FIOCRUZ Publisher, Rio de Janeiro (2000)."},{"key":"ref21","type":"journal-article","article-title":"JoVE Science Education Database. Anesthesia Induction and Maintenance","year":"2023","unstructured":"JoVE Science Education Database. Anesthesia Induction and Maintenance. JoVE .(2023).","journal-title":"JoVE"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4939-9148-8_11","type":"journal-article","article-title":"Exploiting genetically modified dual-reporter strains to monitor experimental Trypanosoma cruzi infections and host-parasite interactions","volume":"1955","author":"Taylor","year":"2019","unstructured":"Taylor, M. C. et al. Exploiting genetically modified dual-reporter strains to monitor experimental Trypanosoma cruzi infections and host-parasite interactions. Methods Mol Biol. 1955, 147-163 (2019).","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"e30061","DOI":"10.1371\/journal.pone.0030061","type":"journal-article","article-title":"Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging","volume":"7","author":"Keyaerts","year":"2012","unstructured":"Keyaerts, M. et al. Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging. PLoS One. 7 (1), e30061 (2012).","journal-title":"PLoS One"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.30802\/AALAS-JAALAS-18-000032","type":"journal-article","article-title":"Comparison of isoflurane, ketamine-dexmedetomidine, and ketamine-xylazine for general anesthesia during oral Procedures in rice rats (Oryzomys palustris)","volume":"58","author":"Jiron","year":"2019","unstructured":"Jiron, J. M. et al. Comparison of isoflurane, ketamine-dexmedetomidine, and ketamine-xylazine for general anesthesia during oral Procedures in rice rats (Oryzomys palustris). J Am Assoc Lab Anim Sci. 58 (1), 40-49 (2019).","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"ref25","article-title":"GoldBio. GoldBio Luciferin In Vivo Handbook - a detailed method for Luciferin preparation and administration for model animals","volume-title":"GoldBio Protocol","year":"2013","unstructured":"GoldBio. GoldBio Luciferin In Vivo Handbook - a detailed method for Luciferin preparation and administration for model animals. GoldBio Protocol. https:\/\/goldbio.com\/documents\/1068\/Luciferin%20in%20vivo%20handbook.pdf (2013)."},{"key":"ref26","article-title":"Revity. Preparation of IVISbriteTM D-Luciferin for in vitro and in vivo bioluminescent assays","volume-title":"Revvity Standard Operate Procedure (Tech Notes)","year":"2023","unstructured":"Revvity. Preparation of IVISbriteTM D-Luciferin for in vitro and in vivo bioluminescent assays. Revvity Standard Operate Procedure (Tech Notes). https:\/\/resources.perkinelmer.com\/lab-solutions\/resources\/docs\/SOP_LuciferinPrep_InVitroInVivo_BLI-Assays.pdf (2023)."},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/17460441.2020.1806233","type":"journal-article","article-title":"Animal models of Chagas disease and their translational value to drug development)","volume":"15","author":"Chatelain","year":"2020","unstructured":"Chatelain, E., Scandale, I. Animal models of Chagas disease and their translational value to drug development. Expert Opin Drug Discov. 15 (12), 1381-1402 (2020).","journal-title":"Expert Opin Drug Discov"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.00689-15","type":"journal-article","article-title":"Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease","volume":"59","author":"Khare","year":"2015","unstructured":"Khare, S. et al. Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease. Antimicrob Agents Chemother. 59 (10), 6385-6394 (2015).","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/jit420","type":"journal-article","article-title":"New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","unstructured":"Bustamante, J. M., Craft, J. M., Crowe, B. D., Ketchie, S. A., Tarleton, R. L. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice. J Infect Dis. 209 (1), 150-162 (2014).","journal-title":"J Infect Dis"},{"issue":"20","key":"ref30","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","type":"journal-article","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas' disease","volume":"370","author":"Molina","year":"2014","unstructured":"Molina, I. et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med. 370 (20), 1899-1908 (2014).","journal-title":"N Engl J Med"},{"key":"ref31","type":"journal-article","article-title":"Science Education Database. Compound Administration II","year":"2023","unstructured":"JoVE Science Education Database. Compound Administration II. JoVE. (2023).","journal-title":"JoVE"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0192-0561(93)90065-7","type":"journal-article","article-title":"Immunosuppressive action of cyclophosphamide in mice: Contribution of some factors to determination of strain differences","volume":"15","author":"Pukhalsky","year":"1993","unstructured":"Pukhalsky, A. L., Toptygina, A. P., Viktorov, V. V. Immunosuppressive action of cyclophosphamide in mice: Contribution of some factors to determination of strain differences. Int J Immunopharmacol. 15 (4), 509-514 (1993).","journal-title":"Int J Immunopharmacol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"e0010827","DOI":"10.1371\/journal.pntd.0010827","type":"journal-article","article-title":"Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure","volume":"16","author":"Francisco","year":"2022","unstructured":"Francisco, A. F. et al. Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure. PLoS Negl Trop Dis. 16 (10), e0010827 (2022).","journal-title":"PLoS Negl Trop Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e200501","DOI":"10.1590\/0074-02760200501","type":"journal-article","article-title":"The translational challenge in Chagas disease drug development","volume":"117","author":"Kratz","year":"2022","unstructured":"Kratz, J. M. et al. The translational challenge in Chagas disease drug development. Mem Inst Oswaldo Cruz. 117, e200501 (2022).","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.phrp.2012.02.002","type":"journal-article","article-title":"In vivo noninvasive small animal molecular imaging","volume":"3","author":"Youn","year":"2012","unstructured":"Youn, H., Hong, K. -J. In vivo noninvasive small animal molecular imaging. Osong Public Health Res Perspect. 3 (1), 48-59 (2012).","journal-title":"Osong Public Health Res Perspect"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12951-022-01648-7","type":"journal-article","article-title":"In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications","volume":"20","author":"Refaat","year":"2022","unstructured":"Refaat, A. et al. In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications. J Nanobiotechnology. 20 (1), 450 (2022).","journal-title":"J Nanobiotechnology"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2967\/jnumed.119.238279","type":"journal-article","article-title":"Optical imaging modalities: Principles and applications in preclinical research and clinical settings","volume":"61","author":"Pirovano","year":"2020","unstructured":"Pirovano, G., Roberts, S., Kossatz, S., Reiner, T. Optical imaging modalities: Principles and applications in preclinical research and clinical settings. J Nucl Med. 61 (10), 1419-1427 (2020).","journal-title":"J Nucl Med"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ab.2005.07.015","type":"journal-article","article-title":"Red- and green-emitting firefly luciferase mutants for bioluminescent reporter applications","volume":"345","author":"Branchini","year":"2005","unstructured":"Branchini, B. R., Southworth, T. L., Khattak, N. F., Michelini, E., Roda, A. Red- and green-emitting firefly luciferase mutants for bioluminescent reporter applications. Anal Biochem. 345 (1), 140-148 (2005).","journal-title":"Anal Biochem"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"041210","DOI":"10.1117\/1.2032388","type":"journal-article","article-title":"Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo","volume":"10","author":"Zhao","year":"2005","unstructured":"Zhao, H. et al. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt. 10 (4), 041210 (2005).","journal-title":"J Biomed Opt"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/path.2656","type":"journal-article","article-title":"Bioluminescent imaging: a critical tool in pre-clinical oncology research","volume":"220","author":"O'Neill","year":"2010","unstructured":"O'Neill, K., Lyons, S. K., Gallagher, W. M., Curran, K. M., Byrne, A. T. Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol. 220 (3), 317-327 (2010).","journal-title":"J Pathol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1038\/s41598-022-18821-5","type":"journal-article","article-title":"A photosensor employing data-driven binning for ultrafast image recognition","volume":"12","author":"Mennel","year":"2022","unstructured":"Mennel, L. et al. A photosensor employing data-driven binning for ultrafast image recognition. Sci Rep. 12 (1), 14441 (2022).","journal-title":"Sci Rep"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"14917","DOI":"10.3390\/s150714917","type":"journal-article","article-title":"Low-light image enhancement using adaptive digital pixel binning","volume":"15","author":"Yoo","year":"2015","unstructured":"Yoo, Y., Im, J., Paik, J. Low-light image enhancement using adaptive digital pixel binning. Sensors. 15 (7), 14917-14931 (2015).","journal-title":"Sensors"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/2472555218823171","type":"journal-article","article-title":"Accelerating drug discovery efforts for trypanosomatidic infections using an integrated transnational academic drug discovery platform","volume":"24","author":"Moraes","year":"2019","unstructured":"Moraes, C. B. et al. Accelerating drug discovery efforts for trypanosomatidic infections using an integrated transnational academic drug discovery platform. SLAS Discov. 24 (3), 346-361 (2019).","journal-title":"SLAS Discov"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pst.426","type":"journal-article","article-title":"Guidelines for accurate EC50\/IC50 estimation","volume":"10","author":"Sebaugh","year":"2011","unstructured":"Sebaugh, J. L. Guidelines for accurate EC50\/IC50 estimation. Pharm Stat. 10 (2), 128-134 (2011).","journal-title":"Pharm Stat"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","type":"journal-article","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","unstructured":"Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51 (D1), D1373-D1380 (2023).","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","type":"journal-article","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"Sharma","year":"2009","unstructured":"Sharma, V., McNeill, J. H. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 157 (6), 907-921 (2009).","journal-title":"Br J Pharmacol"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1021\/acs.jmedchem.3c00514","type":"journal-article","article-title":"The importance of PK-PD","volume":"66","author":"Barrow","year":"2023","unstructured":"Barrow, J. C., Lindsley, C. W. The importance of PK-PD. J Med Chem. 66 (7), 4273-4274 (2023).","journal-title":"J Med Chem"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","type":"journal-article","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","unstructured":"Langford, D. J. et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods. 7 (6), 447-449 (2010).","journal-title":"Nat Methods"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pt.2016.08.009","type":"journal-article","article-title":"Putting infection dynamics at the heart of Chagas disease","volume":"32","author":"Lewis","year":"2016","unstructured":"Lewis, M. D., Kelly, J. M. Putting infection dynamics at the heart of Chagas disease. Trends Parasitol. 32 (11), 899-911 (2016).","journal-title":"Trends Parasitol"},{"key":"ref50","first-page":"389","type":"journal-article","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","unstructured":"Brener, Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. 4, 389-96 (1962).","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-6851(03)00093-8","type":"journal-article","article-title":"Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR","volume":"129","author":"Cummings","year":"2003","unstructured":"Cummings, K. L., Tarleton, R. L. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol. 129 (1), 53-59 (2003).","journal-title":"Mol Biochem Parasitol"},{"key":"ref52","volume-title":"Global BioImaging","author":"Keppler","year":"2024","unstructured":"Keppler, A., Grebnev, G., Reis, Y. Global BioImaging. https:\/\/globalbioimaging.org\/ (2024)."},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"103800","DOI":"10.1016\/j.isci.2022.103800","type":"journal-article","article-title":"Euro-BioImaging - Interdisciplinary research infrastructure bringing together communities and imaging facilities to support excellent research","volume":"25","author":"Pfander","year":"2022","unstructured":"Pfander, C. et al. Euro-BioImaging - Interdisciplinary research infrastructure bringing together communities and imaging facilities to support excellent research. iScience. 25 (2), 103800 (2022).","journal-title":"iScience"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/66740\/demystifying-vivo-bioluminescence-imaging-chagas-disease-mouse-model","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:24:01Z","timestamp":1792599841000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/66740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":53,"journal-issue":{"issue":"207","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3791\/66740","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}